Fumaric acid: a possible new therapy for macular edema?
Int Ophthalmol
; 39(7): 1627-1631, 2019 Jul.
Article
in En
| MEDLINE
| ID: mdl-29959659
INTRODUCTION: Causes of macular edema are multifactorial, but inflammation, vascular factors and mechanical traction are of major importance. Therapeutic options of macular edema depend on the underlying cause. Intravitreal administration of inhibitors of vascular endothelial growth factor leads to inhibition of retinal neovascularization and subsequent edema. OBJECTIVE: Fumaric acid esters are successfully used in dermatology for years according to their antiangiogenic and anti-inflammatory effects. RESULT: For the very first time, we describe a successful therapeutic attempt for macular edema, controlled by optical coherence tomography using fumaric acid esters followed up for 60 months.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Macular Edema
/
Tomography, Optical Coherence
/
Dimethyl Fumarate
/
Macula Lutea
Type of study:
Diagnostic_studies
Limits:
Aged80
/
Female
/
Humans
Language:
En
Journal:
Int Ophthalmol
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: